<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Tetramethylpyrazine (TMPZ) is an active ingredient isolated from a commonly used Chinese herb, Ligusticum wallichii Franchat, which has long been used in China for the treatment of <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, TMPZ significantly attenuated middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO)-induced focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="2" pm="."><plain>Administration of TMPZ at 10 and 20 mg/kg produced concentration-dependent reductions in <z:mpath ids='MPATH_124'>infarct</z:mpath> size compared to that of control rats </plain></SENT>
<SENT sid="3" pm="."><plain>MCAO-induced focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was associated with increases in both nitrotyrosine and inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) expression in ischemic regions </plain></SENT>
<SENT sid="4" pm="."><plain>The expressions of nitrotyrosine and iNOS were markedly inhibited by TMPZ (20 mg/kg) treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, TMPZ (100-250 microM) concentration-dependently inhibited respiratory bursts in human neutrophils stimulated by <z:chebi fb="0" ids="53490">fMLP</z:chebi> (800 nM) and <z:chebi fb="1" ids="53780">PMA</z:chebi> (320 nM) </plain></SENT>
<SENT sid="6" pm="."><plain>TMPZ (100-250 microM) also significantly inhibited neutrophil migration stimulated by <z:chebi fb="0" ids="53490">fMLP</z:chebi> (800 nM) and <z:chebi fb="0" ids="15647">LTB4</z:chebi> (160 nM) </plain></SENT>
<SENT sid="7" pm="."><plain>An electron spin resonance (ESR) method was used to further study the scavenging activity of TMPZ on free radicals formed in human neutrophils </plain></SENT>
<SENT sid="8" pm="."><plain>TMPZ (100 and 200 microM) greatly reduced the ESR signal intensity of <z:chebi fb="1" ids="29191">hydroxyl radical</z:chebi> formation </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, we demonstrate a neuroprotective effect of TMPZ in MCAO-induced focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in vivo </plain></SENT>
<SENT sid="10" pm="."><plain>TMPZ mediates at least part of the free radical-scavenging activity and inhibits neutrophil activation, resulting in a reduction in the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion brain injury </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, TMPZ treatment may represent an ideal approach to lowering the risk of or improving function in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion brain injury-related disorders </plain></SENT>
</text></document>